STAT5 activation by human GH protects insulin-producing cells against interleukin-1beta, interferon-gamma and tumour necrosis factor-alpha-induced apoptosis independent of nitric oxide production.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 16214938)

Published in J Endocrinol on October 01, 2005

Authors

Janne Jensen1, Elisabeth D Galsgaard, Allan E Karlsen, Ying C Lee, Jens H Nielsen

Author Affiliations

1: Department of Medical Biochemistry and Genetics, University of Copenhagen, Panum Institute, Blegdamsvej 3, DK 2200 Copenhagen N, Denmark. jj@imbg.ku.dk

Articles by these authors

The long-acting glucagon-like peptide-1 analogue, liraglutide, inhibits beta-cell apoptosis in vitro. Biochem Biophys Res Commun (2005) 1.63

Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways. J Endocrinol (2006) 1.34

Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic beta-cells. Mol Endocrinol (2003) 1.23

Interleukin 21 therapy increases the density of tumor infiltrating CD8+ T cells and inhibits the growth of syngeneic tumors. Cancer Immunol Immunother (2007) 1.09

STAT5 activity in pancreatic beta-cells influences the severity of diabetes in animal models of type 1 and 2 diabetes. Diabetes (2006) 1.05

Association of a functional 17beta-estradiol sensitive IL6-174G/C promoter polymorphism with early-onset type 1 diabetes in females. Hum Mol Genet (2003) 0.97

Pure samples of individual conformers: the separation of stereoisomers of complex molecules using electric fields. Angew Chem Int Ed Engl (2009) 0.96

Laser-induced alignment and orientation of quantum-state-selected large molecules. Phys Rev Lett (2009) 0.96

Divalent metal transporter 1 regulates iron-mediated ROS and pancreatic β cell fate in response to cytokines. Cell Metab (2012) 0.95

MicroRNA-29a is up-regulated in beta-cells by glucose and decreases glucose-stimulated insulin secretion. Biochem Biophys Res Commun (2012) 0.92

Liraglutide, but not vildagliptin, restores normoglycaemia and insulin content in the animal model of type 2 diabetes, Psammomys obesus. Regul Pept (2009) 0.90

Calcium has a permissive role in interleukin-1beta-induced c-jun N-terminal kinase activation in insulin-secreting cells. Endocrinology (2005) 0.89

Unraveling the pathogenesis of type 1 diabetes with proteomics: present and future directions. Mol Cell Proteomics (2005) 0.89

Quantum-state selection, alignment, and orientation of large molecules using static electric and laser fields. J Chem Phys (2009) 0.88

Treatment with a proton pump inhibitor improves glycaemic control in type 2 diabetic patients - a retrospective analysis. Diabetes Res Clin Pract (2010) 0.87

Novel analytical methods applied to type 1 diabetes genome-scan data. Am J Hum Genet (2004) 0.85

AKAP 18 alpha and gamma have opposing effects on insulin release in INS-1E cells. FEBS Lett (2010) 0.82

Laser-induced 3D alignment and orientation of quantum state-selected molecules. Phys Chem Chem Phys (2009) 0.80

Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts. Immunology (2014) 0.80

Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8+ T-cell density and activity, and enlarges draining lymph nodes. J Immunother (2010) 0.80

Trefoil factors are expressed in human and rat endocrine pancreas: differential regulation by growth hormone. Endocrinology (2006) 0.80

The effect of suppressor of cytokine signaling 3 on GH signaling in beta-cells. Mol Endocrinol (2002) 0.80

CXCL12/SDF-1 over-expression in human insulinomas and its biological relevance. Mol Cell Endocrinol (2008) 0.80

Suppression of FAT/CD36 mRNA by human growth hormone in pancreatic β-cells. Biochem Biophys Res Commun (2011) 0.79

Identification and synthesis of a novel selective partial PPARdelta agonist with full efficacy on lipid metabolism in vitro and in vivo. J Med Chem (2007) 0.79

Antitumorigenic effect of proteasome inhibitors on insulinoma cells. Endocrinology (2004) 0.79

Strain dependent rat iNOS promoter activity--correlation to identified WT1 transcription factor binding site. Autoimmunity (2003) 0.78

Expression and localization of microRNAs in perinatal rat pancreas: role of miR-21 in regulation of cholesterol metabolism. PLoS One (2011) 0.78

Inhibition of the nuclear factor-κB pathway prevents beta cell failure and diet induced diabetes in Psammomys obesus. PLoS One (2010) 0.78

Impulsive laser induced alignment of molecules dissolved in helium nanodroplets. Phys Rev Lett (2013) 0.77

Co-ordinated regulation of neurogenin-3 expression in the maternal and fetal pancreas during pregnancy. Acta Obstet Gynecol Scand (2014) 0.77

Implications for the offspring of circulating factors involved in beta cell adaptation in pregnancy. Acta Obstet Gynecol Scand (2014) 0.77

Developmental biology of the Psammomys obesus pancreas: cloning and expression of the Neurogenin-3 gene. J Histochem Cytochem (2006) 0.77

Sensitive and specific in situ hybridization for early drug discovery. Methods Mol Biol (2014) 0.76

Control and femtosecond time-resolved imaging of torsion in a chiral molecule. J Chem Phys (2012) 0.75

Validation of RNAi by real time PCR. Methods Mol Biol (2011) 0.75

Combined genome and proteome approach to identify new susceptibility genes. Am J Med Genet (2002) 0.75

Involvement of the proteasome in IL-1beta induced suppression of islets of Langerhans in the rat. Ups J Med Sci (2003) 0.75

Prophylactic insulin treatment of syngeneically transplanted pre-diabetic BB-DP rats. Autoimmunity (2003) 0.75

Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats. Autoimmunity (2006) 0.75